Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febril… (NCT07335640) | Clinical Trial Compass
RecruitingNot Applicable
Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital
France100 participantsStarted 2025-06-11
Plain-language summary
Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS.
Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).
Who can participate
Age range
9 Months – 5 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
* First visit to the SAUP for a simple febrile seizure
* Meeting the clinical criteria for FCS:
* Generalized seizure lasting less than 15 minutes
* No post-critical deficit
* No recurrence of seizures within 24 hours
* No personal history of neurological disorders
* Occurrence between January 1, 2022, and May 1, 2025
* First or second episode of FSFS at the time of consultation
* Presence of one of the two parents during the consultation at the SAUP
Exclusion Criteria:
* Patient already seen at the SAUP for FCS
* Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department.
* Child who does not meet the criteria for simple febrile seizures:
* aged less than 9 months or more than 5 years at the time of diagnosis.
* Non-febrile seizure
* Focal seizure
* Seizure duration \>15 min
* Presence of post-critical deficit
* Multiple seizures within 24 hours
* Personal neurological history.
* Seizure occurring outside the period of interest (January 1, 2022 to May 1, 2025)
* Absence of parents during the SAUP consultation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of consultations at the Pediatric Emergency Department for recurrent simple febrile crises.